P-382GC1118, an anti-EGFR monoclonal antibody, blocks irinotecan-induced EGFR activation and exhibits synergistic tumor regression in gastric cancer model
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI